CANRIB 150MG TABLET 60'S

CANRIB 150MG TABLET 60'S may harm an unborn baby and should not be used during pregnancy. It is also not recommended while breastfeeding, as it may pass into breast milk and harm the nursing infant.

Nausea, vomiting, lethargy, diarrhea, appetite loss, and blood cell count abnormalities are typical adverse effects.

There are no specific dietary restrictions associated with CANRIB 150MG TABLET 60'S. However, it's essential to maintain a healthy and balanced diet to support your overall well-being during treatment. It is recommended to avoid grape juice as it increases the blood drug concentration.

CANRIB 150MG TABLET 60'S is usually indicated as maintenance therapy after a person completes a platinum-based chemotherapy regimen for ovarian cancer. However, newer studies are evaluating its solitary efficacy in treating different types of cancers.

CANRIB 150MG TABLET 60'S may cause side effects such as dizziness or fatigue, which could impair your ability to drive or operate machinery safely. If you're unsure, it's best to consult with your healthcare provider for personalized advice based on your specific situation.

There are no known significant interactions of CANRIB 150MG TABLET 60'S with other drugs.

CANRIB 150MG TABLET 60'S can lower blood cell counts, thus it's best to get blood tests done at regular intervals. When undergoing this therapy, stay out of direct sunlight and wear sunscreen with an SPF of at least 50 before going outside. CANRIB 150MG TABLET 60'S should not be stopped without first talking to your doctor. When using this medication, stay away from grapefruit juice as it may raise your blood levels of the drug. It is recommended to inform your doctor about other anticancer drugs you have been taking. It's critical to maintain a sufficient fluid intake because dehydration can exacerbate symptoms such as diarrhea and other gastrointestinal disorders. Even if you feel better or see a change in your symptoms, you should still talk to your doctor before stopping CANRIB 150MG TABLET 60'S.

Remember to attend all scheduled appointments and follow-up visits with your healthcare provider to ensure your treatment is effective and any side effects are managed appropriately. With proper monitoring and management, CANRIB 150MG TABLET 60'S can be an effective treatment option for certain types of cancer.

OLAPARIB is molecule/combination used for making CANRIB 150MG TABLET 60'S.

CANRIB 150MG TABLET 60'S is an oncology drug used in the treatment of cancer.